The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans

Nathan Kuppermann, S. H. Inkelis, R. Saladino

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

In order to gather data regarding the utility of heparin therapy in limiting digit and extremity necrosis resulting from meningococcal purpura fulminans in children, we reviewed the charts of 24 pediatric patients with PF associated with meningococcal disease. Our study population was comprised of the 13 patients who survived more than 2 days. Clinical and outcome data were compared between the group of patients who received therapeutic heparin treatment in the initial 72 hours (≥50 units/kg bolus followed by an infusion, three patients) and the group who did not (10 patients). Demographic and initial clinical and laboratory findings were similar between groups (P > 0.15). When the two groups were compared for dermatologic and orthopedic sequelae, the mean number of digits (6.3 vs. 11.1; P = 0.35) and extremities (1.7 vs. 3.0; P = 0.17) with necrosis was less in those patients who received therapeutic doses of heparin, although the differences were not statistically significant. When only those patients on whom diffuse purpura were noted on admission were compared, these differences were greater. This small, retrospective series suggests that heparin therapy may limit digit and extremity necrosis when used early and in therapeutic doses in meningococcal purpura fulminans. Therefore, a larger, prospective controlled trial is warranted.

Original languageEnglish (US)
Pages (from-to)867-873
Number of pages7
JournalPediatric Infectious Disease Journal
Volume13
Issue number10
StatePublished - 1994

Fingerprint

Purpura Fulminans
Heparin
Necrosis
Extremities
Therapeutics
Purpura
Orthopedics
Demography
Pediatrics

Keywords

  • heparin
  • meningococcal
  • Meningococcus
  • purpura
  • purpura fulminans

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pediatrics, Perinatology, and Child Health

Cite this

The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans. / Kuppermann, Nathan; Inkelis, S. H.; Saladino, R.

In: Pediatric Infectious Disease Journal, Vol. 13, No. 10, 1994, p. 867-873.

Research output: Contribution to journalArticle

@article{c33d3c654df545d5b189ff9c1e503816,
title = "The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans",
abstract = "In order to gather data regarding the utility of heparin therapy in limiting digit and extremity necrosis resulting from meningococcal purpura fulminans in children, we reviewed the charts of 24 pediatric patients with PF associated with meningococcal disease. Our study population was comprised of the 13 patients who survived more than 2 days. Clinical and outcome data were compared between the group of patients who received therapeutic heparin treatment in the initial 72 hours (≥50 units/kg bolus followed by an infusion, three patients) and the group who did not (10 patients). Demographic and initial clinical and laboratory findings were similar between groups (P > 0.15). When the two groups were compared for dermatologic and orthopedic sequelae, the mean number of digits (6.3 vs. 11.1; P = 0.35) and extremities (1.7 vs. 3.0; P = 0.17) with necrosis was less in those patients who received therapeutic doses of heparin, although the differences were not statistically significant. When only those patients on whom diffuse purpura were noted on admission were compared, these differences were greater. This small, retrospective series suggests that heparin therapy may limit digit and extremity necrosis when used early and in therapeutic doses in meningococcal purpura fulminans. Therefore, a larger, prospective controlled trial is warranted.",
keywords = "heparin, meningococcal, Meningococcus, purpura, purpura fulminans",
author = "Nathan Kuppermann and Inkelis, {S. H.} and R. Saladino",
year = "1994",
language = "English (US)",
volume = "13",
pages = "867--873",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans

AU - Kuppermann, Nathan

AU - Inkelis, S. H.

AU - Saladino, R.

PY - 1994

Y1 - 1994

N2 - In order to gather data regarding the utility of heparin therapy in limiting digit and extremity necrosis resulting from meningococcal purpura fulminans in children, we reviewed the charts of 24 pediatric patients with PF associated with meningococcal disease. Our study population was comprised of the 13 patients who survived more than 2 days. Clinical and outcome data were compared between the group of patients who received therapeutic heparin treatment in the initial 72 hours (≥50 units/kg bolus followed by an infusion, three patients) and the group who did not (10 patients). Demographic and initial clinical and laboratory findings were similar between groups (P > 0.15). When the two groups were compared for dermatologic and orthopedic sequelae, the mean number of digits (6.3 vs. 11.1; P = 0.35) and extremities (1.7 vs. 3.0; P = 0.17) with necrosis was less in those patients who received therapeutic doses of heparin, although the differences were not statistically significant. When only those patients on whom diffuse purpura were noted on admission were compared, these differences were greater. This small, retrospective series suggests that heparin therapy may limit digit and extremity necrosis when used early and in therapeutic doses in meningococcal purpura fulminans. Therefore, a larger, prospective controlled trial is warranted.

AB - In order to gather data regarding the utility of heparin therapy in limiting digit and extremity necrosis resulting from meningococcal purpura fulminans in children, we reviewed the charts of 24 pediatric patients with PF associated with meningococcal disease. Our study population was comprised of the 13 patients who survived more than 2 days. Clinical and outcome data were compared between the group of patients who received therapeutic heparin treatment in the initial 72 hours (≥50 units/kg bolus followed by an infusion, three patients) and the group who did not (10 patients). Demographic and initial clinical and laboratory findings were similar between groups (P > 0.15). When the two groups were compared for dermatologic and orthopedic sequelae, the mean number of digits (6.3 vs. 11.1; P = 0.35) and extremities (1.7 vs. 3.0; P = 0.17) with necrosis was less in those patients who received therapeutic doses of heparin, although the differences were not statistically significant. When only those patients on whom diffuse purpura were noted on admission were compared, these differences were greater. This small, retrospective series suggests that heparin therapy may limit digit and extremity necrosis when used early and in therapeutic doses in meningococcal purpura fulminans. Therefore, a larger, prospective controlled trial is warranted.

KW - heparin

KW - meningococcal

KW - Meningococcus

KW - purpura

KW - purpura fulminans

UR - http://www.scopus.com/inward/record.url?scp=0028004139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028004139&partnerID=8YFLogxK

M3 - Article

C2 - 7854884

AN - SCOPUS:0028004139

VL - 13

SP - 867

EP - 873

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 10

ER -